JP2005526494A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005526494A5 JP2005526494A5 JP2003560177A JP2003560177A JP2005526494A5 JP 2005526494 A5 JP2005526494 A5 JP 2005526494A5 JP 2003560177 A JP2003560177 A JP 2003560177A JP 2003560177 A JP2003560177 A JP 2003560177A JP 2005526494 A5 JP2005526494 A5 JP 2005526494A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- polypeptide
- residues
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 77
- 229920001184 polypeptide Polymers 0.000 claims 74
- 102000004196 processed proteins & peptides Human genes 0.000 claims 74
- 125000000539 amino acid group Chemical group 0.000 claims 45
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 43
- 238000000034 method Methods 0.000 claims 42
- 239000012472 biological sample Substances 0.000 claims 20
- 125000003275 alpha amino acid group Chemical group 0.000 claims 16
- 235000001014 amino acid Nutrition 0.000 claims 16
- 150000001413 amino acids Chemical class 0.000 claims 16
- 239000002773 nucleotide Substances 0.000 claims 16
- 125000003729 nucleotide group Chemical group 0.000 claims 16
- 210000001519 tissue Anatomy 0.000 claims 16
- 108091033319 polynucleotide Proteins 0.000 claims 15
- 102000040430 polynucleotide Human genes 0.000 claims 15
- 239000002157 polynucleotide Substances 0.000 claims 15
- 206010061218 Inflammation Diseases 0.000 claims 13
- 230000004054 inflammatory process Effects 0.000 claims 13
- 241000124008 Mammalia Species 0.000 claims 12
- 210000003958 hematopoietic stem cell Anatomy 0.000 claims 11
- 239000000203 mixture Substances 0.000 claims 11
- 244000052769 pathogen Species 0.000 claims 11
- 230000001717 pathogenic effect Effects 0.000 claims 11
- 210000004027 cell Anatomy 0.000 claims 10
- 230000002757 inflammatory effect Effects 0.000 claims 10
- 239000000427 antigen Substances 0.000 claims 9
- 102000036639 antigens Human genes 0.000 claims 9
- 108091007433 antigens Proteins 0.000 claims 9
- 210000002798 bone marrow cell Anatomy 0.000 claims 8
- 210000004976 peripheral blood cell Anatomy 0.000 claims 8
- 210000004698 lymphocyte Anatomy 0.000 claims 7
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims 6
- 102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 claims 6
- 108010002350 Interleukin-2 Proteins 0.000 claims 6
- 108010002386 Interleukin-3 Proteins 0.000 claims 6
- 108090000978 Interleukin-4 Proteins 0.000 claims 6
- 230000028993 immune response Effects 0.000 claims 6
- 239000003550 marker Substances 0.000 claims 6
- 125000006850 spacer group Chemical group 0.000 claims 6
- 238000013518 transcription Methods 0.000 claims 6
- 230000035897 transcription Effects 0.000 claims 6
- 206010028980 Neoplasm Diseases 0.000 claims 5
- 201000011510 cancer Diseases 0.000 claims 5
- 108020001507 fusion proteins Proteins 0.000 claims 5
- 102000037865 fusion proteins Human genes 0.000 claims 5
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims 4
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims 4
- 230000000295 complement effect Effects 0.000 claims 4
- 238000012258 culturing Methods 0.000 claims 4
- 201000010099 disease Diseases 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 239000013604 expression vector Substances 0.000 claims 4
- 230000028709 inflammatory response Effects 0.000 claims 4
- 239000003053 toxin Substances 0.000 claims 4
- 231100000765 toxin Toxicity 0.000 claims 4
- 102000004190 Enzymes Human genes 0.000 claims 3
- 108090000790 Enzymes Proteins 0.000 claims 3
- 241001465754 Metazoa Species 0.000 claims 3
- 210000001744 T-lymphocyte Anatomy 0.000 claims 3
- 102000003675 cytokine receptors Human genes 0.000 claims 3
- 108010057085 cytokine receptors Proteins 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 229940079593 drug Drugs 0.000 claims 3
- 239000003937 drug carrier Substances 0.000 claims 3
- 230000003394 haemopoietic effect Effects 0.000 claims 3
- 238000009396 hybridization Methods 0.000 claims 3
- 208000027866 inflammatory disease Diseases 0.000 claims 3
- 239000006249 magnetic particle Substances 0.000 claims 3
- 102000039446 nucleic acids Human genes 0.000 claims 3
- 108020004707 nucleic acids Proteins 0.000 claims 3
- 150000007523 nucleic acids Chemical class 0.000 claims 3
- 239000002243 precursor Substances 0.000 claims 3
- 239000000523 sample Substances 0.000 claims 3
- 230000000638 stimulation Effects 0.000 claims 3
- 239000000758 substrate Substances 0.000 claims 3
- 239000003981 vehicle Substances 0.000 claims 3
- 108020004711 Nucleic Acid Probes Proteins 0.000 claims 2
- 230000001154 acute effect Effects 0.000 claims 2
- 239000005557 antagonist Substances 0.000 claims 2
- 230000024245 cell differentiation Effects 0.000 claims 2
- 230000004663 cell proliferation Effects 0.000 claims 2
- 208000037976 chronic inflammation Diseases 0.000 claims 2
- 208000037893 chronic inflammatory disorder Diseases 0.000 claims 2
- 230000004069 differentiation Effects 0.000 claims 2
- 239000012634 fragment Substances 0.000 claims 2
- 230000002401 inhibitory effect Effects 0.000 claims 2
- 239000002853 nucleic acid probe Substances 0.000 claims 2
- 230000035755 proliferation Effects 0.000 claims 2
- 235000018102 proteins Nutrition 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 230000004936 stimulating effect Effects 0.000 claims 2
- 230000001629 suppression Effects 0.000 claims 2
- 206010009900 Colitis ulcerative Diseases 0.000 claims 1
- 208000035473 Communicable disease Diseases 0.000 claims 1
- 208000011231 Crohn disease Diseases 0.000 claims 1
- 208000037487 Endotoxemia Diseases 0.000 claims 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
- 241001529936 Murinae Species 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- 206010040047 Sepsis Diseases 0.000 claims 1
- 206010040070 Septic Shock Diseases 0.000 claims 1
- 206010044248 Toxic shock syndrome Diseases 0.000 claims 1
- 231100000650 Toxic shock syndrome Toxicity 0.000 claims 1
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 1
- 230000000890 antigenic effect Effects 0.000 claims 1
- 206010003246 arthritis Diseases 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 210000000601 blood cell Anatomy 0.000 claims 1
- 210000001185 bone marrow Anatomy 0.000 claims 1
- 210000004748 cultured cell Anatomy 0.000 claims 1
- 235000018417 cysteine Nutrition 0.000 claims 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 238000002372 labelling Methods 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 210000001616 monocyte Anatomy 0.000 claims 1
- 230000002093 peripheral effect Effects 0.000 claims 1
- 102000005962 receptors Human genes 0.000 claims 1
- 108020003175 receptors Proteins 0.000 claims 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35032502P | 2002-01-18 | 2002-01-18 | |
| US60/350,325 | 2002-01-18 | ||
| US37532302P | 2002-04-25 | 2002-04-25 | |
| US60/375,323 | 2002-04-25 | ||
| US43531502P | 2002-12-19 | 2002-12-19 | |
| US60/435,315 | 2002-12-19 | ||
| PCT/US2003/001984 WO2003060090A2 (en) | 2002-01-18 | 2003-01-21 | Novel cytokine zcytor17 ligand |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005526494A JP2005526494A (ja) | 2005-09-08 |
| JP2005526494A5 true JP2005526494A5 (enExample) | 2006-03-02 |
| JP4795641B2 JP4795641B2 (ja) | 2011-10-19 |
Family
ID=27407940
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003560177A Expired - Fee Related JP4795641B2 (ja) | 2002-01-18 | 2003-01-21 | 新規サイトカインｚｃｙｔｏｒ１７リガンド |
Country Status (21)
| Country | Link |
|---|---|
| US (12) | US7064186B2 (enExample) |
| EP (3) | EP1476541B1 (enExample) |
| JP (1) | JP4795641B2 (enExample) |
| KR (1) | KR101013401B1 (enExample) |
| CN (2) | CN100575482C (enExample) |
| AT (3) | ATE401390T1 (enExample) |
| AU (2) | AU2003225525B2 (enExample) |
| BR (1) | BR0306979A (enExample) |
| CA (1) | CA2473686C (enExample) |
| CY (1) | CY1112833T1 (enExample) |
| DE (2) | DE60322188D1 (enExample) |
| DK (3) | DK2230299T3 (enExample) |
| ES (3) | ES2351678T3 (enExample) |
| IL (3) | IL163066A (enExample) |
| NO (1) | NO332266B1 (enExample) |
| PL (1) | PL211833B1 (enExample) |
| PT (1) | PT2230299E (enExample) |
| RU (2) | RU2490276C2 (enExample) |
| SI (1) | SI2230299T1 (enExample) |
| WO (1) | WO2003060090A2 (enExample) |
| ZA (1) | ZA200405695B (enExample) |
Families Citing this family (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE455852T1 (de) | 1999-06-02 | 2010-02-15 | Chugai Pharmaceutical Co Ltd | Neues hämopoietin rezeptorprotein nr10 |
| AU7445900A (en) | 1999-09-27 | 2001-04-30 | Chugai Seiyaku Kabushiki Kaisha | Novel hemopoietin receptor protein, nr12 |
| US20030096339A1 (en) * | 2000-06-26 | 2003-05-22 | Sprecher Cindy A. | Cytokine receptor zcytor17 |
| JP4511349B2 (ja) * | 2002-01-18 | 2010-07-28 | ザイモジェネティクス，インコーポレイティド | サイトカイン受容体ｚｃｙｔｏｒ１７マルチマー |
| EP1476541B1 (en) | 2002-01-18 | 2008-07-16 | ZymoGenetics, Inc. | Cytokine (zcytor17 ligand) |
| US9738700B2 (en) | 2002-01-18 | 2017-08-22 | Zymogenetics Inc. | ZCYTOR17 heterodimeric cytokine receptor |
| WO2005040380A1 (ja) * | 2003-10-29 | 2005-05-06 | Bml, Inc. | げっ歯類動物の免疫応答調節蛋白質 |
| JP2007068402A (ja) * | 2003-12-26 | 2007-03-22 | Bml Inc | 免疫応答調節蛋白質 |
| JP5179189B2 (ja) | 2004-11-03 | 2013-04-10 | ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド | Ｔ細胞タンパク質及びそれをコードするヌクレオチド |
| ES2579758T3 (es) * | 2005-01-28 | 2016-08-16 | Zymogenetics, Inc. | Preparaciones homogéneas de IL-31 |
| EP1856150A2 (en) * | 2005-02-14 | 2007-11-21 | ZymoGenetics, Inc. | Methods of treating diseases which are mediated by cutaneous lymphocyte antigen positive cells |
| WO2006088855A1 (en) * | 2005-02-14 | 2006-08-24 | Zymogenetics, Inc. | Methods of treating skin disorders using an il-31ra antagonist |
| AU2012202218B2 (en) * | 2005-02-14 | 2014-05-22 | National Jewish Medical And Research Center | Methods Of Treating Diseases Which Are Mediated By Cutaneous Lymphocyte Antigen Positive Cells |
| EP1869222A4 (en) * | 2005-04-15 | 2010-01-20 | Oncomethylome Sciences S A | METHYLATION MARKERS FOR THE DIAGNOSIS AND TREATMENT OF CANCER |
| US8101183B2 (en) | 2005-05-06 | 2012-01-24 | Zymogentics, Inc. | Variable region sequences of IL-31 monoclonal antibodies |
| JP5065253B2 (ja) * | 2005-05-06 | 2012-10-31 | ザイモジェネティクス， インコーポレイテッド | Ｉｌ−３１モノクローナル抗体とその使用法 |
| US20130216542A1 (en) | 2005-05-06 | 2013-08-22 | Zymogenetics, Inc. | Variable region sequences of il-31 monoclonal antibodies and methods of use |
| MX2008008831A (es) * | 2006-01-10 | 2009-03-04 | Zymogenetics Inc | Metodos para tratar dolor e inflamacion en tejidos neuronales usando antagonistas il-31. |
| DK2006381T3 (en) | 2006-03-31 | 2016-02-22 | Chugai Pharmaceutical Co Ltd | PROCEDURE FOR REGULATING ANTIBODIES BLOOD PHARMACOKINETICS |
| PE20080333A1 (es) | 2006-06-08 | 2008-06-15 | Chugai Pharmaceutical Co Ltd | Agentes para prevenir o tratar enfermedades inflamatorias |
| DK2594586T3 (en) * | 2006-09-01 | 2014-11-17 | Zymogenetics Inc | Monoclonal il-31 antibodies and methods of use thereof |
| US8859218B2 (en) | 2008-06-13 | 2014-10-14 | Oncohealth Corp. | In situ detection of early stages and late stages HPV infection |
| AU2008204823A1 (en) * | 2007-01-10 | 2008-07-17 | Zymogenetics, Inc | Methods of using IL-31 to treat airway hyper-responsiveness and asthma |
| DK2202245T3 (en) * | 2007-09-26 | 2016-11-21 | Chugai Pharmaceutical Co Ltd | A method of modifying an antibody isoelectric point VIA amino acid substitution in CDR |
| ES2687808T3 (es) | 2007-09-26 | 2018-10-29 | Chugai Seiyaku Kabushiki Kaisha | Región constante de anticuerpo modificado |
| WO2009052487A2 (en) * | 2007-10-18 | 2009-04-23 | University Of South Florida | Method of detecting oncogenesis of hematopoietic cells |
| MY162546A (en) | 2007-12-05 | 2017-06-15 | Chugai Pharmaceutical Co Ltd | Therapeutic agent for pruritus |
| MX337081B (es) * | 2007-12-05 | 2016-02-10 | Chugai Pharmaceutical Co Ltd | Anticuerpo anti-nr10 y su uso. |
| AU2008333131B2 (en) | 2007-12-07 | 2013-10-24 | Merck Serono S/A | Humanized antibody molecules specific for IL-31 |
| PT2708559T (pt) | 2008-04-11 | 2018-05-16 | Chugai Pharmaceutical Co Ltd | Molécula de ligação ao antigénio capaz de se ligar repetidamente a duas ou mais moléculas de antigénio |
| WO2009147537A2 (en) | 2008-05-27 | 2009-12-10 | Dako Denmark A/S | Compositions and methods for detection of chromosomal aberrations with novel hybridization buffers |
| EP2401395A1 (en) | 2009-02-26 | 2012-01-04 | Dako Denmark A/S | Compositions and methods for rna hybridization applications |
| JP2010210772A (ja) | 2009-03-13 | 2010-09-24 | Dainippon Screen Mfg Co Ltd | 液晶表示装置の製造方法 |
| WO2010107110A1 (ja) | 2009-03-19 | 2010-09-23 | 中外製薬株式会社 | 抗体定常領域改変体 |
| TWI646193B (zh) | 2009-03-19 | 2019-01-01 | 中外製藥股份有限公司 | 抗體恆定區域改變體 |
| US8892184B2 (en) | 2010-10-18 | 2014-11-18 | Siemens Medical Solutions Usa, Inc. | Systems and methods for reducing interference in a dual modality imaging system |
| MX365235B (es) | 2010-11-30 | 2019-05-28 | Chugai Pharmaceutical Co Ltd | Molécula de unión a antígeno capaz de unir repetidamente a la pluralidad de moléculas de antígeno. |
| US8790651B2 (en) | 2011-07-21 | 2014-07-29 | Zoetis Llc | Interleukin-31 monoclonal antibody |
| WO2013025248A1 (en) * | 2011-08-12 | 2013-02-21 | Mello Biotechnology, Inc. | Inducable expression from the eukaryotic pol -2 promoter in prokaryotes |
| WO2013046033A1 (en) | 2011-09-30 | 2013-04-04 | Dako Denmark A/S | Hybridization compositions and methods using formamide |
| EP3252173A1 (en) | 2011-10-21 | 2017-12-06 | Dako Denmark A/S | Hybridization compositions and methods |
| US10196662B2 (en) * | 2012-08-10 | 2019-02-05 | Mello Biotechnology, Inc. | Composition for producing microRNA precursors as drugs for enhancing wound healing and production method of the microRNA precursors |
| KR101882366B1 (ko) | 2013-05-30 | 2018-07-30 | 키닉사 파마슈티컬스, 리미티드 | 온코스타틴 m 수용체 항원 결합 단백질 |
| WO2015164107A1 (en) | 2014-04-23 | 2015-10-29 | Emory University | Compositions of gm-csf and interleukin fusions for immune modulation and uses related thereto |
| US20170072019A1 (en) | 2014-05-12 | 2017-03-16 | Rappaport Family Institute For Research In The Medical Sciences | Compositions comprising il-31 and uses thereof |
| ES3036076T3 (en) | 2015-04-14 | 2025-09-12 | Chugai Pharmaceutical Co Ltd | Pharmaceutical composition for prevention and/or treatment of atopic dermatitis containing il-31 antagonist as active ingredient |
| WO2016167263A1 (ja) | 2015-04-14 | 2016-10-20 | 中外製薬株式会社 | Ｉｌ－３１アンタゴニストを有効成分として含有する、アトピー性皮膚炎の予防用及び／又は治療用医薬組成物 |
| CN104826100A (zh) * | 2015-04-16 | 2015-08-12 | 浙江海隆生物科技有限公司 | 一种猪瘟病毒重组亚单位疫苗的制备方法与应用 |
| DE102015215840B4 (de) * | 2015-08-19 | 2017-03-23 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Multiaperturabbildungsvorrichtung, Abbildungssystem und Verfahren zum Bereitstellen einer Multiaperturabbildungsvorrichtung |
| WO2018156180A1 (en) | 2017-02-24 | 2018-08-30 | Kindred Biosciences, Inc. | Anti-il31 antibodies for veterinary use |
| BR112022006590A2 (pt) | 2019-11-20 | 2022-06-28 | Chugai Pharmaceutical Co Ltd | Preparação contendo anticorpos |
| CN111337666B (zh) * | 2020-02-12 | 2021-04-02 | 山东大学 | I-motif重组介导的FRET探针及其原位成像癌细胞表面蛋白质同源二聚化的应用 |
| TWI765431B (zh) * | 2020-11-25 | 2022-05-21 | 長庚大學 | 核酸放大系統及其方法 |
Family Cites Families (77)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4054646A (en) * | 1973-07-30 | 1977-10-18 | General Electric | Method and apparatus for detection of antibodies and antigens |
| DK368882A (da) | 1981-08-25 | 1983-02-26 | Alan John Kingsman | Expessions vektorer |
| US4579821A (en) | 1981-11-23 | 1986-04-01 | University Patents, Inc. | Control of DNA sequence transcription |
| US4656134A (en) | 1982-01-11 | 1987-04-07 | Board Of Trustees Of Leland Stanford Jr. University | Gene amplification in eukaryotic cells |
| US4486533A (en) | 1982-09-02 | 1984-12-04 | St. Louis University | Filamentous fungi functional replicating extrachromosomal element |
| US4599311A (en) | 1982-08-13 | 1986-07-08 | Kawasaki Glenn H | Glycolytic promotersfor regulated protein expression: protease inhibitor |
| US4977092A (en) | 1985-06-26 | 1990-12-11 | Amgen | Expression of exogenous polypeptides and polypeptide products including hepatitis B surface antigen in yeast cells |
| US4601978A (en) | 1982-11-24 | 1986-07-22 | The Regents Of The University Of California | Mammalian metallothionein promoter system |
| US4603044A (en) | 1983-01-06 | 1986-07-29 | Technology Unlimited, Inc. | Hepatocyte Directed Vesicle delivery system |
| US4713339A (en) | 1983-01-19 | 1987-12-15 | Genentech, Inc. | Polycistronic expression vector construction |
| US4661454A (en) | 1983-02-28 | 1987-04-28 | Collaborative Research, Inc. | GAL1 yeast promoter linked to non galactokinase gene |
| US5139936A (en) | 1983-02-28 | 1992-08-18 | Collaborative Research, Inc. | Use of the GAL1 yeast promoter |
| US4650764A (en) | 1983-04-12 | 1987-03-17 | Wisconsin Alumni Research Foundation | Helper cell |
| US4870008A (en) | 1983-08-12 | 1989-09-26 | Chiron Corporation | Secretory expression in eukaryotes |
| US4931373A (en) | 1984-05-25 | 1990-06-05 | Zymogenetics, Inc. | Stable DNA constructs for expression of α-1 antitrypsin |
| US4766073A (en) | 1985-02-25 | 1988-08-23 | Zymogenetics Inc. | Expression of biologically active PDGF analogs in eucaryotic cells |
| EP0184576B1 (en) | 1984-12-06 | 1990-06-27 | Fina Research S.A. | Promoters for the expression of foreign genes in yeast, plasmids comprising them, and uses thereof for the production of polypeptides |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| GR860984B (en) | 1985-04-17 | 1986-08-18 | Zymogenetics Inc | Expression of factor vii and ix activities in mammalian cells |
| US4882279A (en) | 1985-10-25 | 1989-11-21 | Phillips Petroleum Company | Site selective genomic modification of yeast of the genus pichia |
| US4935349A (en) | 1986-01-17 | 1990-06-19 | Zymogenetics, Inc. | Expression of higher eucaryotic genes in aspergillus |
| GB8611832D0 (en) | 1986-05-15 | 1986-06-25 | Holland I B | Polypeptide |
| US4980289A (en) | 1987-04-27 | 1990-12-25 | Wisconsin Alumni Research Foundation | Promoter deficient retroviral vector |
| US5063154A (en) | 1987-06-24 | 1991-11-05 | Whitehead Institute For Biomedical Research | Pheromone - inducible yeast promoter |
| ATE140963T1 (de) | 1988-01-22 | 1996-08-15 | Zymogenetics Inc | Verfahren zur herstellung von sekretierten rezeptoranalogen |
| US5567584A (en) | 1988-01-22 | 1996-10-22 | Zymogenetics, Inc. | Methods of using biologically active dimerized polypeptide fusions to detect PDGF |
| US4956288A (en) | 1988-04-22 | 1990-09-11 | Biogen, Inc. | Method for producing cells containing stably integrated foreign DNA at a high copy number, the cells produced by this method, and the use of these cells to produce the polypeptides coded for by the foreign DNA |
| US5037743A (en) | 1988-08-05 | 1991-08-06 | Zymogenetics, Inc. | BAR1 secretion signal |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US5162228A (en) | 1988-12-28 | 1992-11-10 | Takeda Chemical Industries, Ltd. | Gylceraldehyde-3-phosphate dehydrogenase gene and promoter |
| US5124263A (en) | 1989-01-12 | 1992-06-23 | Wisconsin Alumni Research Foundation | Recombination resistant retroviral helper cell and products produced thereby |
| US5116964A (en) | 1989-02-23 | 1992-05-26 | Genentech, Inc. | Hybrid immunoglobulins |
| US5399346A (en) | 1989-06-14 | 1995-03-21 | The United States Of America As Represented By The Department Of Health And Human Services | Gene therapy |
| US6217857B1 (en) * | 1989-06-28 | 2001-04-17 | Schering Corporation | Cytokine synthesis inhibitory factor (IL-10) and pharmaceutical compositions thereof |
| US5162222A (en) | 1989-07-07 | 1992-11-10 | Guarino Linda A | Use of baculovirus early promoters for expression of foreign genes in stably transformed insect cells or recombinant baculoviruses |
| IL99552A0 (en) | 1990-09-28 | 1992-08-18 | Ixsys Inc | Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof |
| JP3202999B2 (ja) | 1991-01-31 | 2001-08-27 | 協和醗酵工業株式会社 | 肝移行性リポソーム製剤 |
| US5298418A (en) | 1991-09-16 | 1994-03-29 | Boyce Thompson Institute For Plant Research, Inc. | Cell line isolated from larval midgut tissue of Trichoplusia ni |
| US5641670A (en) | 1991-11-05 | 1997-06-24 | Transkaryotic Therapies, Inc. | Protein production and protein delivery |
| EP0749319A1 (en) | 1992-09-14 | 1996-12-27 | Pfizer Inc. | Immortalized cells and uses therefor |
| JPH09501055A (ja) | 1993-07-30 | 1997-02-04 | ユニバーシティ オブ メディシン アンド デンティストリー オブ ニュージャージー | 初代リンパ球への効率的遺伝子転移 |
| US6117679A (en) | 1994-02-17 | 2000-09-12 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| US5492841A (en) * | 1994-02-18 | 1996-02-20 | E. I. Du Pont De Nemours And Company | Quaternary ammonium immunogenic conjugates and immunoassay reagents |
| US5783672A (en) | 1994-05-26 | 1998-07-21 | Immunex Corporation | Receptor for oncostatin M |
| RU2102988C1 (ru) * | 1995-02-10 | 1998-01-27 | Зинченко Елена Вениаминовна | Препарат с иммуномодулирующими свойствами |
| US6074849A (en) | 1995-07-19 | 2000-06-13 | Genetics Institute, Inc. | Polynucleotides encoding human CTLA-8 related proteins |
| WO1997017451A2 (en) | 1995-11-09 | 1997-05-15 | Zymogenetics, Inc. | Production of gad65 in methylotrophic yeast |
| US6265184B1 (en) * | 1995-12-20 | 2001-07-24 | Icos Corporation | Polynucleotides encoding chemokine receptor 88C |
| US5792850A (en) * | 1996-05-23 | 1998-08-11 | Zymogenetics, Inc. | Hematopoietic cytokine receptor |
| JP2002514049A (ja) | 1996-07-17 | 2002-05-14 | ザイモジェネティクス，インコーポレイティド | ピヒア・メタノリカの栄養要求性突然変異体の製造 |
| AU718510B2 (en) | 1996-07-17 | 2000-04-13 | Zymogenetics Inc. | Transformation of pichia methanolica |
| WO2002000690A2 (en) | 2000-06-23 | 2002-01-03 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| DE69738539T2 (de) | 1996-12-03 | 2009-03-26 | Amgen Fremont Inc. | Vollkommen humane Antikörper die EGFR binden |
| GB9819420D0 (en) | 1998-09-07 | 1998-10-28 | Glaxo Group Ltd | Novel receptor |
| JP2002543786A (ja) * | 1999-05-11 | 2002-12-24 | ザイモジェネティクス，インコーポレイティド | サイトカイン受容体マウスｚｃｙｔｏｒ１０ |
| ATE455852T1 (de) | 1999-06-02 | 2010-02-15 | Chugai Pharmaceutical Co Ltd | Neues hämopoietin rezeptorprotein nr10 |
| AU6531101A (en) | 2000-06-02 | 2001-12-17 | Genentech Inc | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| JP2004501628A (ja) * | 2000-06-26 | 2004-01-22 | ザイモジェネティクス，インコーポレイティド | サイトカイン受容体ｚｃｙｔｏｒ１７ |
| US20030096339A1 (en) | 2000-06-26 | 2003-05-22 | Sprecher Cindy A. | Cytokine receptor zcytor17 |
| CA2416456A1 (en) | 2000-07-20 | 2002-01-31 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| JP2005507632A (ja) | 2000-10-06 | 2005-03-24 | イミュネックス・コーポレーション | ヘマトポエチン受容体、ｈｐｒ１およびｈｐｒ２ |
| WO2002077230A1 (fr) | 2001-03-26 | 2002-10-03 | Chugai Seiyaku Kabushiki Kaisha | Variants d'epissage nr10 |
| JP4511349B2 (ja) | 2002-01-18 | 2010-07-28 | ザイモジェネティクス，インコーポレイティド | サイトカイン受容体ｚｃｙｔｏｒ１７マルチマー |
| EP1476541B1 (en) | 2002-01-18 | 2008-07-16 | ZymoGenetics, Inc. | Cytokine (zcytor17 ligand) |
| US7303896B2 (en) | 2002-02-25 | 2007-12-04 | Genentech, Inc. | Nucleic acid encoding novel type-1 cytokine receptor GLM-R |
| JP2008534915A (ja) * | 2005-01-19 | 2008-08-28 | アイアールエム・リミテッド・ライアビリティ・カンパニー | 複数窪み容器の位置決め装置、システム、コンピュータ・プログラム生成物、及び方法 |
| ES2579758T3 (es) * | 2005-01-28 | 2016-08-16 | Zymogenetics, Inc. | Preparaciones homogéneas de IL-31 |
| EP1856150A2 (en) * | 2005-02-14 | 2007-11-21 | ZymoGenetics, Inc. | Methods of treating diseases which are mediated by cutaneous lymphocyte antigen positive cells |
| WO2006088855A1 (en) | 2005-02-14 | 2006-08-24 | Zymogenetics, Inc. | Methods of treating skin disorders using an il-31ra antagonist |
| US20130216542A1 (en) | 2005-05-06 | 2013-08-22 | Zymogenetics, Inc. | Variable region sequences of il-31 monoclonal antibodies and methods of use |
| US8101183B2 (en) | 2005-05-06 | 2012-01-24 | Zymogentics, Inc. | Variable region sequences of IL-31 monoclonal antibodies |
| JP5065253B2 (ja) | 2005-05-06 | 2012-10-31 | ザイモジェネティクス， インコーポレイテッド | Ｉｌ−３１モノクローナル抗体とその使用法 |
| MX2008008831A (es) | 2006-01-10 | 2009-03-04 | Zymogenetics Inc | Metodos para tratar dolor e inflamacion en tejidos neuronales usando antagonistas il-31. |
| DK2594586T3 (en) | 2006-09-01 | 2014-11-17 | Zymogenetics Inc | Monoclonal il-31 antibodies and methods of use thereof |
| AU2008204823A1 (en) | 2007-01-10 | 2008-07-17 | Zymogenetics, Inc | Methods of using IL-31 to treat airway hyper-responsiveness and asthma |
| AU2008333131B2 (en) | 2007-12-07 | 2013-10-24 | Merck Serono S/A | Humanized antibody molecules specific for IL-31 |
-
2003
- 2003-01-21 EP EP03729693A patent/EP1476541B1/en not_active Expired - Lifetime
- 2003-01-21 DE DE60322188T patent/DE60322188D1/de not_active Expired - Lifetime
- 2003-01-21 AT AT03729693T patent/ATE401390T1/de active
- 2003-01-21 EP EP08102636A patent/EP1961811B1/en not_active Expired - Lifetime
- 2003-01-21 KR KR1020047011182A patent/KR101013401B1/ko not_active Expired - Fee Related
- 2003-01-21 WO PCT/US2003/001984 patent/WO2003060090A2/en not_active Ceased
- 2003-01-21 PL PL371586A patent/PL211833B1/pl unknown
- 2003-01-21 RU RU2008118227/10A patent/RU2490276C2/ru not_active IP Right Cessation
- 2003-01-21 ES ES08102636T patent/ES2351678T3/es not_active Expired - Lifetime
- 2003-01-21 CN CN03806171A patent/CN100575482C/zh not_active Expired - Fee Related
- 2003-01-21 US US10/352,554 patent/US7064186B2/en not_active Expired - Lifetime
- 2003-01-21 ES ES10168189T patent/ES2377188T3/es not_active Expired - Lifetime
- 2003-01-21 BR BR0306979-6A patent/BR0306979A/pt not_active Application Discontinuation
- 2003-01-21 CA CA2473686A patent/CA2473686C/en not_active Expired - Fee Related
- 2003-01-21 RU RU2004125165/13A patent/RU2360923C2/ru not_active IP Right Cessation
- 2003-01-21 DK DK10168189.8T patent/DK2230299T3/da active
- 2003-01-21 CN CN200910263704A patent/CN101843895A/zh active Pending
- 2003-01-21 JP JP2003560177A patent/JP4795641B2/ja not_active Expired - Fee Related
- 2003-01-21 DK DK08102636.1T patent/DK1961811T3/da active
- 2003-01-21 DE DE60333963T patent/DE60333963D1/de not_active Expired - Lifetime
- 2003-01-21 PT PT10168189T patent/PT2230299E/pt unknown
- 2003-01-21 AT AT10168189T patent/ATE536406T1/de active
- 2003-01-21 SI SI200332116T patent/SI2230299T1/sl unknown
- 2003-01-21 EP EP10168189A patent/EP2230299B1/en not_active Expired - Lifetime
- 2003-01-21 AU AU2003225525A patent/AU2003225525B2/en not_active Ceased
- 2003-01-21 DK DK03729693T patent/DK1476541T3/da active
- 2003-01-21 AT AT08102636T patent/ATE478944T1/de active
- 2003-01-21 ES ES03729693T patent/ES2310660T3/es not_active Expired - Lifetime
-
2004
- 2004-07-15 IL IL163066A patent/IL163066A/en not_active IP Right Cessation
- 2004-07-16 ZA ZA2004/05695A patent/ZA200405695B/en unknown
- 2004-08-17 NO NO20043419A patent/NO332266B1/no not_active IP Right Cessation
-
2005
- 2005-12-13 US US11/301,764 patent/US7459293B2/en not_active Expired - Fee Related
-
2006
- 2006-12-12 US US11/609,499 patent/US7425325B2/en not_active Expired - Fee Related
- 2006-12-13 US US11/610,126 patent/US7507795B2/en not_active Expired - Fee Related
- 2006-12-19 US US11/613,091 patent/US7531636B2/en not_active Expired - Fee Related
-
2008
- 2008-08-18 US US12/193,665 patent/US8013124B2/en not_active Expired - Fee Related
- 2008-10-22 AU AU2008230054A patent/AU2008230054B2/en not_active Ceased
-
2009
- 2009-01-29 US US12/362,318 patent/US7740834B2/en not_active Expired - Fee Related
-
2010
- 2010-04-08 US US12/756,959 patent/US8124378B2/en not_active Expired - Fee Related
-
2011
- 2011-01-04 IL IL210455A patent/IL210455A/en not_active IP Right Cessation
- 2011-01-04 IL IL210454A patent/IL210454A/en not_active IP Right Cessation
-
2012
- 2012-01-26 US US13/359,049 patent/US8778344B2/en not_active Expired - Fee Related
- 2012-03-06 CY CY20121100217T patent/CY1112833T1/el unknown
-
2014
- 2014-06-05 US US14/296,488 patent/US9605062B2/en not_active Expired - Fee Related
-
2017
- 2017-02-10 US US15/429,750 patent/US20180155418A1/en not_active Abandoned
-
2018
- 2018-09-27 US US16/144,289 patent/US20190338020A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005526494A5 (enExample) | ||
| CA2473686A1 (en) | Novel cytokine zcytor17 ligand | |
| JP7138735B2 (ja) | Ｒｏｒ１癌の治療および転移の阻害に使用するための抗体およびワクチン | |
| CN115244077B (zh) | 蛋白质治疗剂 | |
| ES2599477T3 (es) | Antígeno 75 de linfocitos (Ly75) | |
| US11046745B2 (en) | Peptide mimotopes of the CD3 T-cell co-receptor epsilon chain and uses thereof | |
| CN114539411B (zh) | 一种ror1抗体或其抗原结合片段 | |
| EA030777B1 (ru) | Анти-альфа-синуклеинсвязывающие молекулы | |
| TW201837056A (zh) | Ｂ７－ｈ３抗體、其抗原結合片段及其醫藥用途 | |
| JP2007537197A5 (enExample) | ||
| CN110770252A (zh) | 抗p53抗体 | |
| JP2003524415A5 (enExample) | ||
| JP2021046417A (ja) | 抗Ａｇｇｒｕｓモノクローナル抗体、ＣＬＥＣ−２との結合に必要なＡｇｇｒｕｓの領域、及びＡｇｇｒｕｓ−ＣＬＥＣ‐２結合阻害剤のスクリーニング方法 | |
| CN116496394A (zh) | 抗s100蛋白的抗体、检测s100蛋白的试剂和试剂盒 | |
| EP3731861A1 (en) | T cell receptors for tumor specific proteasome splice variants and uses thereof | |
| JPH08501925A (ja) | 糖蛋白ｐに対するモノクローナル抗体 | |
| AU2016281649B2 (en) | Antigenic peptides and uses thereof for diagnosing and treating autism | |
| KR20110122807A (ko) | 피에이유에프(ｐａｕｆ) 특이적인 인간 단일클론항체, 이를 포함하는 암 치료용 조성물, 이를 이용하는 암의 진단방법 | |
| CN110713544B (zh) | 融合基因plekha6-ntrk3及其在lch中的应用 | |
| CN118108842A (zh) | 人源化抗cd24抗体及其应用 | |
| JPH0767689A (ja) | 抗ｌｄ７８ポリペプチドモノクローン抗体 | |
| CN117510636B (zh) | Gprc5d抗体及其应用 | |
| WO1997045451A1 (fr) | Anticorps anti-lect2 humains, cellules le produisant et ses procede et materiel de dosage | |
| EP2099821B1 (en) | Gene and protein that homes to developing microvessels | |
| WO2024155805A2 (en) | Etv1 monoclonal antibodies |